A5062486589- Diabetes Management and Research
- Diabetes Treatment and Management
- Pharmacology and Obesity Treatment
- Asthma and respiratory diseases
- Diabetes Management and Education
- Primary Care and Health Outcomes
- Diabetes and associated disorders
- Pancreatic function and diabetes
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet and metabolism studies
- Obesity and Health Practices
- Metabolism, Diabetes, and Cancer
- Lipoproteins and Cardiovascular Health
- Dementia and Cognitive Impairment Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Sodium Intake and Health
- Respiratory and Cough-Related Research
- Gastroesophageal reflux and treatments
- Blood Pressure and Hypertension Studies
- Pneumonia and Respiratory Infections
- Helicobacter pylori-related gastroenterology studies
- Health Systems, Economic Evaluations, Quality of Life
- Eosinophilic Esophagitis
- Pharmaceutical Practices and Patient Outcomes
Touro University California
2019-2022
Roseman University of Health Sciences
2017-2018
University of North Carolina at Chapel Hill
2008-2014
Cabarrus College of Health Sciences
2004-2014
University of Washington
2014
University of California, Irvine
1991-2009
American Academy of Family Physicians
1985-2008
Stamford Hospital
1999-2008
Carolinas Medical Center
2005
Icahn School of Medicine at Mount Sinai
1999
The results of a prospective, randomized comparative study the efficacy and toxicity clindamycin, chloramphenicol, ticarcillin in treatment, concomitantly with gentamicin to ensure complete aerobic coverage, 175 patients serious mixed aerobic/anaerobic intraabdominal or female genital tract sepsis are reported. In group sepsis, 33 (79%) 42 treated 43 (81%) 53 35 (90%) 39 were cured. 16 (94%) 17 11 (100%) 12 (92%) 13 Diarrhea occurred most frequently clindamycin (P < 0.001), hematologic...
Asthma is a heterogenous respiratory disease, usually associated with chronic airway inflammation and hyper-responsiveness, which affects an estimated 339 million people worldwide. Severe asthma approximately 5–10% of patients asthma, 17–34 globally, more than half whom have uncontrolled disease. carries substantial burden including unpredictable symptoms potentially life-threatening flare-ups. Furthermore, severe has on health care systems economies In 2018, group experts from the clinical...